Format: PDF
The blood screening market is expected to reach USD 3.32 billion by 2024, rising over the forecast period at a CAGR of 8.66%. The growing demand for donated blood, the increasing number of blood donations, the increasing prevalence of infectious diseases, and the increasing prevalence of new pathogens are driving this market’s growth.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED
1.3.2 GEOGRAPHIC SCOPE
1.3.3 YEARS CONSIDERED
1.4 CURRENCY
1.5 LIMITATIONS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 SECONDARY SOURCES
2.1.2 PRIMARY DATA
2.1.2.1 PRIMARY SOURCES
2.1.2.2 BREAKDOWN OF PRIMARIES
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
2.2.3 MARKET SHARE ESTIMATION
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 RESEARCH ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.2.4 CHALLENGES
5 INDUSTRY TRENDS
5.1 INTRODUCTION
5.2 VALUE CHAIN
6 BLOOD SCREENING MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
6.2 Reagents and Kits
6.3 NAT Reagents and Kits
6.4 ELISA Reagents and Kits
6.5 Others
7 BLOOD SCREENING MARKET, BY TECHNOLOGY
7.1 INTRODUCTION
7.2 Transcription-Mediated Amplification
7.3 Real-time Polymerase Chain Reaction
7.4 Fluorescent immunoassay
7.5 Rapid Tests
7.6 Western Blot Assays
7.7 Other
8 BLOOD SCREENING MARKET, BY END USER
8.1 INTRODUCTION
8.2 Blood Banks
8.3 Hospitals
9 GEOGRAPHIC ANALYSIS
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 US
9.2.2 CANADA
9.2.3 MEXICO
9.3 EUROPE
9.3.1 UK
9.2.4 GERMANY
9.2.5 FRANCE
9.2.6 ITALY
9.2.7 REST OF EUROPE
9.3 ASIA PACIFIC
9.4.1 CHINA
9.4.2 JAPAN
9.4.3 SOUTH KOREA
9.4.4 INDIA
9.4.5 REST OF APAC
9.5 REST OF THE WORLD (ROW)
9.5.1 MIDDLE EAST
9.5.2 SOUTH AMERICA
9.5.3 AFRICA
10 MARKET ENTROPY
10.1 NEW PRODUCT LAUNCHES
10.2 M&A’s, COLLABORATIONS, JVs, AND PARTNERSHIPS
11 COMPANY PROFILES
11.1 INTRODUCTION
(Business overview, Products offered, Recent developments)*
11.2 KEY PLAYERS
11.2.1 F. Hoffmann-La Roche
11.2.2 GE Healthcare
11.2.3 Becton, Dickson and Company
11.2.4 Danaher Corporation
11.2.5 Abbott Laboratories
11.2.6 Siemens Healthineers
11.2.7 Biomérieux
11.2.8 Bio-Rad Laboratories
11.2.9 Ortho Clinical Diagnostics
11.2.10 Thermo Fisher Scientific
11.2.11 Company 11 & More
*Details on Business overview, Products offered, Recent developments might not be captured in case of unlisted companies.
12 APPENDIX
12.1 SOURCES
12.2 ABBREVIATIONS
Take a look at this complimentary sample which comprises of a variety of market data points such as trend analyses, market estimates, and forecasts. You can explore and evaluate it on your own.
Send me Free SampleOr View Our License Options:
$3,850.00 – $5,850.00
Industry Coverage: Global Market Studies has a broad range of industry coverage, spanning various sectors such as healthcare, technology, retail, automotive, and many others. This means that clients can rely on us to provide valuable insights into their respective industries, helping them make informed business decisions.
Our team of experts has years of experience in the market research industry, and they have honed their skills in data analysis, market forecasting, and trend analysis. They are also adept at using advanced research tools and techniques to gather and analyze data, providing clients with accurate and reliable insights.
We understand that each client has unique research needs, and we tailor our research solutions to meet their specific requirements. We work closely with our clients to understand their objectives and provide customized research solutions that address their business challenges.
We are committed to innovation and are constantly exploring new research methods and techniques to provide our clients with cutting-edge insights. This enables us to stay ahead of the curve and deliver the best possible research outcomes.
At Global Market Studies, our clients are at the center of everything we do. We pride ourselves on providing excellent customer service and support, and we are always available to address our clients’ concerns and questions.
Accurate market data is crucial to a successful business strategy. With an 85% + accuracy in all reports, makes us one of the best and most accurate firms in the world.
Need Customized Report ?Call NowThe blood screening market is expected to reach USD 3.32 billion by 2024, rising over the forecast period at a CAGR of 8.66%. The growing demand for donated blood, the increasing number of blood donations, the increasing prevalence of infectious diseases, and the increasing prevalence of new pathogens are driving this market’s growth.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED
1.3.2 GEOGRAPHIC SCOPE
1.3.3 YEARS CONSIDERED
1.4 CURRENCY
1.5 LIMITATIONS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 SECONDARY SOURCES
2.1.2 PRIMARY DATA
2.1.2.1 PRIMARY SOURCES
2.1.2.2 BREAKDOWN OF PRIMARIES
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
2.2.3 MARKET SHARE ESTIMATION
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 RESEARCH ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.2.4 CHALLENGES
5 INDUSTRY TRENDS
5.1 INTRODUCTION
5.2 VALUE CHAIN
6 BLOOD SCREENING MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
6.2 Reagents and Kits
6.3 NAT Reagents and Kits
6.4 ELISA Reagents and Kits
6.5 Others
7 BLOOD SCREENING MARKET, BY TECHNOLOGY
7.1 INTRODUCTION
7.2 Transcription-Mediated Amplification
7.3 Real-time Polymerase Chain Reaction
7.4 Fluorescent immunoassay
7.5 Rapid Tests
7.6 Western Blot Assays
7.7 Other
8 BLOOD SCREENING MARKET, BY END USER
8.1 INTRODUCTION
8.2 Blood Banks
8.3 Hospitals
9 GEOGRAPHIC ANALYSIS
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 US
9.2.2 CANADA
9.2.3 MEXICO
9.3 EUROPE
9.3.1 UK
9.2.4 GERMANY
9.2.5 FRANCE
9.2.6 ITALY
9.2.7 REST OF EUROPE
9.3 ASIA PACIFIC
9.4.1 CHINA
9.4.2 JAPAN
9.4.3 SOUTH KOREA
9.4.4 INDIA
9.4.5 REST OF APAC
9.5 REST OF THE WORLD (ROW)
9.5.1 MIDDLE EAST
9.5.2 SOUTH AMERICA
9.5.3 AFRICA
10 MARKET ENTROPY
10.1 NEW PRODUCT LAUNCHES
10.2 M&A’s, COLLABORATIONS, JVs, AND PARTNERSHIPS
11 COMPANY PROFILES
11.1 INTRODUCTION
(Business overview, Products offered, Recent developments)*
11.2 KEY PLAYERS
11.2.1 F. Hoffmann-La Roche
11.2.2 GE Healthcare
11.2.3 Becton, Dickson and Company
11.2.4 Danaher Corporation
11.2.5 Abbott Laboratories
11.2.6 Siemens Healthineers
11.2.7 Biomérieux
11.2.8 Bio-Rad Laboratories
11.2.9 Ortho Clinical Diagnostics
11.2.10 Thermo Fisher Scientific
11.2.11 Company 11 & More
*Details on Business overview, Products offered, Recent developments might not be captured in case of unlisted companies.
12 APPENDIX
12.1 SOURCES
12.2 ABBREVIATIONS
Unleashing revenue potential through strategic market research involves identifying untapped market opportunities, understanding consumer needs and preferences, and developing targeted strategies to capitalize on them. By leveraging data-driven insights, businesses can optimize product offerings, pricing strategies, and marketing efforts to drive revenue growth and stay ahead of competitors.
